更新术后列线图纳入阳性淋巴结数目预测根治性前列腺切除术后疾病复发
该研究基于1995至2012年间7789例接受根治性前列腺切除及盆腔淋巴结清扫的患者,比较纳入淋巴结侵犯与纳入阳性淋巴结数目的两种复发预测模型。结果显示,按阳性淋巴结数目分层仅在淋巴结阳性患者中提供额外区分能力,c-index较淋巴结侵犯模型高0.01(95%CI 0.001-0.024),该模型待外部验证后可用于患者咨询和临床试验分层。
要点
- 7789例根治性前列腺切除患者中,491例(6.3%)有淋巴结病变,387例(5.0%)有1-2枚阳性淋巴结,104例(1.3%)有≥3枚阳性淋巴结。
- 在全队列中,阳性淋巴结数目数据未提高c-index。
- 仅在淋巴结阳性患者中,阳性淋巴结数目模型的c-index比淋巴结侵犯模型高0.01(95%CI 0.001-0.024)。
核心结论
- 按阳性淋巴结数目分层为评估淋巴结阳性患者的风险提供了额外区分能力。
- 该模型待外部验证后,可用于该亚组患者的咨询和临床试验分层。
研究设计与样本
- 1995年至2012年在一家三级转诊中心接受根治性前列腺切除和盆腔淋巴结清扫的7789例患者。
- 比较纳入淋巴结侵犯与追踪阳性淋巴结数目的两种复发预测模型,使用Harrell c-index和校准评估区分度,并进行10折交叉验证以校正模型过拟合。
主要发现
- 491例患者(6.3%)有淋巴结病变,其中387例(5.0%)有1-2枚阳性淋巴结,104例(1.3%)有≥3枚阳性淋巴结。
- 在全队列中,阳性淋巴结数目数据未提高c-index。
- 仅在淋巴结阳性患者中,阳性淋巴结数目模型的c-index比淋巴结侵犯模型高0.01(95%置信区间0.001-0.024)。
- 以1年生化复发50%为切点,7789例患者中有40例会被重新分类;以10年生化复发40%为切点,7789例患者中有36例会被重新分类。
临床怎么用
- 该模型待外部验证后,可用于淋巴结阳性患者的咨询和临床试验分层。
局限性
- 该模型需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant number of patients with minimal lymph node disease at radical prostatectomy (RP) and pelvic lymph node dissection (PLND) have better than expected long-term outcomes. We explored whether stratification by number of positive nodes enhances our institutional prediction model for biochemical recurrence after RP. METHODS: A total of 7789 patients underwent RP and pelvic lymph node dissection from 1995 to 2012 at a tertiary referral center. We compared two recurrence prediction models: one incorporated lymph node invasion and the other tracked the number of positive nodes. Existing and updated models' discrimination was assessed using Harrell's c-index and calibration. The 10-fold cross-validation was performed to correct for model overfitting. RESULTS: Of the 491 patients (6.3%) harboring nodal disease, 387 (5.0%) had 1-2 positive nodes and 104 (1.3%) had ⩾3 positive nodes. Data on number of positive nodes did not improve the c-index for the cohort as a whole. When we assessed discrimination for node-positive patients only, c-index for the model with number of positive nodes was 0.01 (95% confidence interval 0.001-0.024) higher than the model with lymph node invasion. Illustrative examples were provided by reclassification tables using number of positive lymph nodes. For instance, 40 of 7789 patients would be reclassified with a cutoff point of 50% for biochemical recurrence at 1 year, and 36 of 7789 patients would be reclassified with a cutoff point of 40% for biochemical recurrence at 10 years. CONCLUSIONS: Stratification by number of positive lymph nodes provided additional discriminative ability for evaluating risk in node-positive patients. Pending external validation, this model could be used for patient counseling and clinical trial stratification in this subpopulation.
引用
- Nguyen DP, Kent M, Vilaseca A, et al. Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy. Prostate Cancer Prostatic Dis. 2016. PMID: 27958385. doi:10.1038/pcan.2016.60
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。